⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4073653 | 0.72 | — | — | |
| SCHEMBL6200636 | 0.69 | — | — | |
| SCHEMBL1896274 | 0.69 | — | — | |
| SCHEMBL19661004 | 0.69 | — | — | |
| SCHEMBL2127275 | 0.69 | — | — | |
| SCHEMBL6970625 | 0.67 | — | — | |
| SCHEMBL15434587 | 0.67 | — | — | |
| SCHEMBL1896275 | 0.67 | — | — | |
| SCHEMBL19660934 | 0.67 | — | — | |
| SCHEMBL12847695 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9601778-B2 | Electrode active material , electrode and secondary battery | MURATA MANUFACTURING CO., LTD. (JP) | 2017-03-21 | — | — | US | claimed |
| EP-2782172-B1 | ELECTRODE ACTIVE MATERIAL, ELECTRODE, AND SECONDARY BATTERY | MURATA MANUFACTURING CO (JP) | 2016-09-28 | — | — | EP | claimed |
| CN-104011916-B | Electrode active material, electrode and secondary cell | MURATA MANUFACTURING CO.,LTD. (JP) | 2016-06-01 | — | — | CN | claimed |
| EP-2782172-A1 | ELECTRODE ACTIVE MATERIAL, ELECTRODE, AND SECONDARY BATTERY | Murata Manufacturing Co. Ltd. (JP) | 2014-09-24 | — | — | EP | claimed |
| US-20140248535-A1 | ELECTRODE ACTIVE MATERIAL , ELECTRODE AND SECONDARY BATTERY | MURATA MANUFACTURING CO.,LTD. (JP) | 2014-09-04 | — | — | US | claimed |
| EP-3912979-B1 | TYROSINE KINASE INHIBITORS | PRINCIPIA BIOPHARMA INC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12503475-B2 | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | CENTESSA PHARMACEUTICALS (UK) LIMITED (GB) | 2025-12-23 | — | — | US | disclosed |
| US-20250197402-A1 | Tyrosine Kinase Inhibitors | PRINCIPIA BIOPHARMA INC. (US) | 2025-06-19 | — | — | US | disclosed |
| CN-113149983-B | Tyrosine kinase inhibitors | 普林斯匹亚生物制药公司 | 2024-03-29 | — | — | CN | disclosed |
| WO-2024041586-A1 | PRODRUG OF JAK KINASE INHIBITOR | 启元生物(杭州)有限公司 | 2024-02-29 | — | — | WO | disclosed |
| US-20230271973-A1 | BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS | CENTESSA PHARMACEUTICALS (OREXIA) LIMITED (GB) | 2023-08-31 | — | — | US | disclosed |
| US-20230234921-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | ASCLETIS BIOSCIENCE CO., LTD. (CN) | 2023-07-27 | — | — | US | disclosed |
| EP-0771209-A2 | NOVEL PEPTIDES | Merck & Co., Inc. (a New Jersey corp.) (US) | 1997-05-07 | — | — | EP | disclosed |
| WO-1996040629-A1 | TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS | SUGEN, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996000503-A1 | NOVEL PEPTIDES | MERCK & CO., INC. (US) | 1996-01-11 | — | — | WO | disclosed |
| WO-1995024190-A2 | RECEPTOR TYROSINE KINASE INHIBITORS FOR INHIBITING CELL PROLIFERATIVE DISORDERS AND COMPOSITIONS THEREOF | SUGEN, INC. (US) | 1995-09-14 | — | — | WO | disclosed |
| EP-0067436-B1 | DIAMINO ISOTHIAZOLE -1-OXIDES AND -1,1-DIOXIDES AS GASTRIC SECRETION INHIBITORS | MERCK & CO. INC. (US) | 1986-07-23 | — | — | EP | disclosed |
| EP-0069063-B1 | AMINOALKYL-SUBSTITUTED AROMATIC OR HETEROCYCLIC COMPOUNDS AND PROCESS FOR THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1986-01-22 | — | — | EP | disclosed |
| EP-0069063-A1 | Aminoalkyl-substituted aromatic or heterocyclic compounds and process for their preparation | CIBA-GEIGY AG (CH) | 1983-01-05 | — | — | EP | disclosed |
| EP-0067436-A2 | Diamino isothiazole -1-oxides and -1,1-dioxides as gastric secretion inhibitors | MERCK & CO. INC. (US) | 1982-12-22 | — | — | EP | disclosed |